Old Web
English
Sign In
Acemap
>
authorDetail
>
Weining Robieson
Weining Robieson
Medicine
Risk analysis (engineering)
Management science
Subgroup analysis
Covariate
3
Papers
52
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Statistical considerations in a delayed-start design to demonstrate disease modification effect in neurodegenerative disorders
2019
Pharmaceutical Statistics
Deli Wang
Weining Robieson
Jun Zhao
Catherine Wiener
Gary G. Koch
Show All
Source
Cite
Save
Citations (0)
Lessons Learned From Multi-regional Trials With Signals of Treatment Effect Heterogeneity:
2018
Therapeutic Innovation & Regulatory Science
Gang Li
Hui Quan
Gordon Lan
Soo Peter Ouyang
Fei Chen
Weining Robieson
William Wang
Bruce Binkowitz
Shuai Sammy Yuan
Yoko Tanaka
Josh Chen
Nobushige Matsuoka
Lanju Zhang
Song Yang
Paul Gallo
Show All
Source
Cite
Save
Citations (0)
Evidence for Therapeutic Equivalence of Lansoprazole 30mg and Esomeprazole 40mg in the Treatment of Erosive Oesophagitis
2002
Clinical Drug Investigation
Colin W. Howden
E. David Ballard
Weining Robieson
Show All
Source
Cite
Save
Citations (52)
1